Puma Biotechnology, Inc. (PBYI)

Oncology Corporate Profile

Stock Performance

105.9000
1.4000

3 Month Stock History Chart

HQ Location

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024

Company Description

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2-positive breast cancer and patients with non-small cell lung cancer, breast cancer and other solid tumors that have a HER2 mutation.

Website: http://www.pumabiotechnology.com/

Brand Generic Indication
Nerlynx™neratinibNerlynx™ is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy.
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
neratinib / PB272 (+ xeloda)tyrosine kinase inhibitorBreast cancerIII
neratinib / PB272tyrosine kinase inhibitorBreast cancerIII
neratinib / PB272 (+ pacitaxel)tyrosine kinase inhibitorBreast cancerII
neratinib / PB272 (+ torisel)tyrosine kinase inhibitorBreast cancerII
neratinib / PB272tyrosine kinase inhibitorVarious cancer typesII
neratinib / PB272 (+ trastuzumab emtansine)tyrosine kinase inhibitorBreast cancer (HER2+)I

View additional information on product candidates here »

Source: http://www.pumabiotechnology.com/

Recent News Headlines

8/21/2017 06:22 am

8/21/2017 06:22 am

8/21/2017 06:22 am

8/21/2017 06:22 am

8/21/2017 06:22 am

8/11/2017 06:19 pm

8/11/2017 06:19 pm

8/10/2017 06:19 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/10/2017 06:19 am

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/9/2017 12:19 pm

8/4/2017 06:19 pm

8/4/2017 06:19 am

8/1/2017 06:19 pm

7/31/2017 12:19 pm

7/28/2017 06:19 pm

7/28/2017 06:19 pm

7/28/2017 06:19 pm

7/21/2017 12:19 pm

7/18/2017 06:19 pm